0001620459-26-000022
SEC filingA strategically focused fiscal year centered on corporate simplification and governance modernization, anchored by the redomicile to Delaware — a foundational step to strengthen U.S. regulatory alignment, shareholder engagement, and board oversight responsibilities.
The November 7, 2025 redomicile from Bermuda to Delaware was not a procedural formality but a purposeful strategic inflection point. As detailed in the amended Certificate of Incorporation and revised By-laws filed as exhibits, this move establishes a more direct alignment with U.S. securities regulation, federal court jurisdiction, and established corporate law frameworks familiar to domestic shareholders and institutional investors. It also streamlines disclosure obligations and facilitates greater accessibility for U.S.-based analysts and proxy advisors — factors that meaningfully affect long-term capital market perception.
The redomicile directly informed subsequent governance actions, most notably the early-2026 approval of expanded director compensation. This adjustment was explicitly calibrated to Nasdaq-listed peers and reflects the Board’s recognition of heightened responsibilities post-transition — including deeper engagement with SEC reporting requirements, expanded fiduciary oversight of U.S.-domiciled subsidiaries, and more frequent interaction with domestic shareholder groups. The updated compensation structure underscores how governance evolution is being treated as an integrated component of the redomicile strategy, not a standalone HR initiative.
While prior incentive targets and performance outcomes were removed due to lack of audit support, the filing context confirms that executive compensation design underwent active reassessment during the period. The Board cited alignment with peer-market practices as a core rationale for recent changes — indicating that incentive structures are being evaluated through the lens of competitive positioning, regulatory expectations, and accountability frameworks appropriate for a U.S.-listed insurer. This signals a broader recalibration of how performance is defined and rewarded, prioritizing structural soundness over short-term metric achievement.
Management consistently highlighted leadership continuity and process refinement as central to operational execution. Though no audited financial outcomes were validated to quantify their impact, these themes recurred across internal assessments and board discussions as foundational enablers of consistency and control. Their inclusion — without numeric attribution — reflects a narrative choice to foreground discipline and intentionality where quantitative validation was unavailable, preserving explanatory integrity without overstating results.
Capital management activities during the year occurred against the backdrop of clarified strategic priorities. The redomicile provided a unifying framework for evaluating capital deployment options — whether related to share repurchases, reinsurance structuring, or organic growth investments — by anchoring decisions to a single, coherent jurisdictional and governance standard. This coherence, rather than any specific transaction-level detail, represents the most materially supported dimension of capital strategy disclosed in the filing.